Related Experiment Video

Updated: Jun 10, 2026

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
02:34

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

The use of inhaled corticosteroids in the wheezy under 5-year-old child

B R Davies1, W D Carroll

  • 1Nottingham University, Hospitals NHS Trust, Nottingham, UK.

Archives of Disease in Childhood. Education and Practice Edition
|August 3, 2010
PubMed

Insights

Inhaled corticosteroids are recommended for children with asthma. However, diagnosing and treating wheeze in children under five remains challenging due to limited evidence and differing expert opinions.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Inhaled corticosteroids (ICS) are the cornerstone of long-term asthma management.
  • Current guidelines recommend ICS for children's asthma control.
  • Diagnosing asthma and wheezing phenotypes in children under five presents significant challenges.

Purpose of the Study:

  • To review recent evidence and expert opinions on managing wheeze in young children.
  • To address the controversies surrounding ICS use in children under five.
  • To highlight advancements in understanding and treating early childhood wheeze.

Main Methods:

  • Literature review of recent studies on ICS efficacy and safety in young children.
  • Synthesis of current expert consensus and treatment guidelines.
  • Analysis of diagnostic challenges and wheezing phenotypes in pre-schoolers.

Main Results:

  • Limited data exists on ICS effectiveness and side effects in children under five.
  • Asthma diagnosis in this age group is difficult due to multiple causes of wheeze.
  • Expert opinions and recent evidence are beginning to clarify optimal management strategies.

Conclusions:

  • Improved evidence is emerging for the management of wheeze in young children.
  • Further research is needed to establish definitive treatment protocols for early childhood asthma.
  • Recent advances aim to improve outcomes for young children experiencing wheeze.

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: